(A Top Pick July 11, 2017. Down 7%). This has gone down even as interest rates have come up. He is holding with it, with a very small position. Life insurers are not participating in the financials rally as much as he expected. His model price shows a 47% upside, but the market appears to dislike some aspect of MetLife’s balance sheet and he is not sure what that is. Because he is not sure what is wrong, he would not buy it.
One of the biggest life insurance companies. Spawned off the individual insurance part in a company called Brighthouse earlier this year. MetLife has been hurt lately by some controversy. In the long run still likes the outlook for both Brighthouse and Metlife, and rising interests rate do help insurance companies a lot.
(A Top Pick July 11/17 Down 2%) All the insurers are being helped by rising interest rates, yet the stock price has not increased. He is disappointed by the performance, but will continue to stick with it. He has a model price about 30% higher. Yield 3.5%.
(A Top Pick May 1/17, Up 5%) It spun out Bright House. He continues to own both. They had to take a hit on benefits that people were not getting and should have.
This is a diversified insurance company with a bias to life. It is in a good capital situation. The technical chart is too boom and bust, which he can’t explain. Insurance broadly has generally under-performed and he thinks you are taking more risk than the reward you are getting. He would prefer straight financial stocks instead.
Metlife is a American stock, trading under the symbol MET-N on the New York Stock Exchange (MET). It is usually referred to as NYSE:MET or MET-N
In the last year, there was no coverage of Metlife published on Stockchase.
Metlife was recommended as a Top Pick by on . Read the latest stock experts ratings for Metlife.
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
0 stock analysts on Stockchase covered Metlife In the last year. It is a trending stock that is worth watching.
On 2022-07-01, Metlife (MET-N) stock closed at a price of $63.68.